
- /
- Supported exchanges
- / F
CARL ZEISS MEDITEC ADR 1 (AFXA F) stock market data APIs
CARL ZEISS MEDITEC ADR 1 Financial Data Overview
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get CARL ZEISS MEDITEC ADR 1 data using free add-ons & libraries
Get CARL ZEISS MEDITEC ADR 1 Fundamental Data
CARL ZEISS MEDITEC ADR 1 Fundamental data includes:
- Net Revenue: 2 066 M
- EBITDA: 294 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-07
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CARL ZEISS MEDITEC ADR 1 News

The past three years for Carl Zeiss Meditec (ETR:AFX) investors has not been profitable
Carl Zeiss Meditec AG (ETR:AFX) shareholders should be happy to see the share price up 21% in the last month. But that is small recompense for the exasperating returns over three years. Regrettably, t...


ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. DUBLIN, Calif. and JENA, ...

An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 41% Undervalued
Key Insights The projected fair value for Carl Zeiss Meditec is €77.77 based on 2 Stage Free Cash Flow to Equity Carl Zeiss Meditec is estimated to be 41% undervalued based on current share price o...

Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over the past month. Given that the market rewards strong financials in the long-term, we w...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.